Wild-type cardiac amyloidosis with a negative bone scintigraphy: A case report.

Rev Port Cardiol

Cardiology Department, Hospital de Santa Cruz, Lisbon, Portugal; Advanced Heart Failure and Heart Transplantation Department, Cardiology, Hospital de Santa Cruz, Lisbon, Portugal.

Published: March 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.repc.2023.07.007DOI Listing

Publication Analysis

Top Keywords

wild-type cardiac
4
cardiac amyloidosis
4
amyloidosis negative
4
negative bone
4
bone scintigraphy
4
scintigraphy case
4
case report
4
wild-type
1
amyloidosis
1
negative
1

Similar Publications

Dementia Care Practice.

Alzheimers Dement

December 2024

VA Boston Healthcare System, Jamaica Plain, MA, USA.

Background: Mixed dementia type - Alzheimer's Disease (AD), cerebral amyloid angiopathy (CAA), and vascular - is vastly recognized as a cause of dementia in older adults. Whereas CAA, primarily leptomeningeal, is a frequent complication in hereditary transthyretin cardiac amyloidosis (TTRCA), it is unusually reported in association with wild-type TTR, with or without polyneuropathy. The knowledge of mixed dementia and wild-type TTR association is even scarcer.

View Article and Find Full Text PDF

Vitamin B, or pantothenate, forms the molecular "backbone" of coenzyme A (CoA), which is essential for more than a hundred biochemical reactions in humans. Genetic defects that disrupt the CoA pathway cause severe degenerative disorders that may be amenable to treatment with compounds that can bypass the metabolic block. The pantothenate metabolite, 4'-phosphopantetheine (4'PPT), can serve as an alternative substrate for cellular CoA synthesis and may therefore be an essential nutrient in managing disorders where pantothenate cannot meet all metabolic requirements.

View Article and Find Full Text PDF

Background: Sphingosine-1 phosphate (S1P) is a bioactive lipid molecule that modulates inflammation and hepatic lipid metabolism in MASLD, which affects 1 in 3 people and increases the risk of liver fibrosis and hepatic cancer. S1P can be generated by 2 isoforms of sphingosine kinase (SphK). SphK1 is well-studied in metabolic diseases.

View Article and Find Full Text PDF

Binding of to dystrophin impairs the membrane trafficking of Nav1.5 protein and increases ventricular arrhythmia susceptibility.

Elife

January 2025

Department of Pharmacology (The Key Laboratory of Cardiovascular Research, Ministry of Education) at College of Pharmacy, Harbin Medical University, Harbin, China.

Dystrophin is a critical interacting protein of Nav1.5 that determines its membrane anchoring in cardiomyocytes. Long noncoding RNAs (lncRNAs) are involved in the regulation of cardiac ion channels, while their influence on sodium channels remains unexplored.

View Article and Find Full Text PDF

Dietary sulfur amino acid restriction (SAAR) elicits various health benefits, some mediated by fibroblast growth factor 21 (FGF21). However, research on SAAR's effects on the heart is limited and presents mixed findings. This study aimed to evaluate SAAR-induced molecular alterations associated with cardiac remodeling and their dependence on FGF21.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!